Incyte (INCY) EV to EBITDA (2010 - 2026)
Incyte's EV to EBITDA was 9.72 in Q2 2026, up 14.7% from 8.48 a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EV to EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Incyte's EV to EBITDA was 4.11 through Jun 30, 2026, up 17.5% year-over-year; for FY2025, it was 9.96, down 86.6% from FY2024.
- In earlier years, EV to EBITDA was 74.38 in FY2024 (+401.6%), 14.83 in FY2023 (-34.5%), 22.64 in FY2022 (+5.0%) and 21.56 in FY2021.
- Quarterly EV to EBITDA has moved between 8.48 (Q2 2025) and 309.96 (Q3 2024) over five years.
- Compared with a year earlier, EV to EBITDA was higher in three of the last seven quarters, with growth averaging 38.7%.
- The best year-over-year quarter for EV to EBITDA over five years was Q4 2024 (growth of 401.6%); the worst was Q3 2025 (a decline of 97.2%).
- Per Business Quant data, INCY's EV to EBITDA in the three quarters before Q2 2026 was 8.68 (Q1 2026), 9.96 (Q4 2025) and 8.71 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Incyte | 24.76 Bn | 9.70 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72 |
| Mar 31, 2026 | 8.68 |
| Dec 31, 2025 | 9.96 |
| Sep 30, 2025 | 8.71 |
| Jun 30, 2025 | 8.48 |
| Mar 31, 2025 | 35.28 |
| Dec 31, 2024 | 74.38 |
| Sep 30, 2024 | 309.96 |
| Jun 30, 2024 | 98.78 |
| Mar 31, 2024 | 11.57 |
| Dec 31, 2023 | 14.83 |
| Sep 30, 2023 | 16.19 |
| Jun 30, 2023 | 20.90 |
| Mar 31, 2023 | 23.30 |
| Dec 31, 2022 | 22.64 |
| Sep 30, 2022 | 17.31 |
| Jun 30, 2022 | 18.13 |
| Mar 31, 2022 | 22.65 |
| Dec 31, 2021 | 21.56 |
| Sep 30, 2021 | 18.56 |
API Access
Incyte EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();